Display Options:
Total: 92
Small molecule
Approved
OTHER
ORAL
Pain; Osteoarthritis, Knee; Tennis Elbow; Renal Colic; Wounds and Injuries; Arthralgia; Arthritis, Rheumatoid; Eye Diseases; Myalgia; Osteoarthritis; Rheumatic Diseases
Cyclooxygenase inhibitor
Small molecule
Approved
OTHER
ORAL
Amyotrophic Lateral Sclerosis; Anxiety; Dementia; Depressive Disorder; Schizophrenia; Psychotic Disorders; Tics; Tourette Syndrome
Dopamine receptor antagonist
Small molecule
Approved
OTHER
NASAL; ORAL; TRANSDERMAL
Aging; Attention Deficit Disorder with Hyperactivity; Cocaine-Related Disorders; Memory Disorders; Sarcoidosis; Sarcoidosis, Pulmonary; Schizophrenia; Substance-Related Disorders; Alcohol Drinking; Carcinoma; Cognitive Dysfunction; Depressive Disorder; Parkinson Disease; Postoperative Nausea and Vomiting; Sarcoma; Wounds and Injuries; Heart Failure; Lung Neoplasms; Marijuana Abuse; Pulmonary Disease, Chronic Obstructive; Severe Acute Respiratory Syndrome; Smoking; Smoking Cessation; Uterine Cervical Neoplasms; Tobacco Use Disorder
Neuronal acetylcholine receptor; alpha4/beta2 agonist
Small molecule
Approved
OTHER
ORAL
Alcoholism; Bipolar Disorder; Cognitive Dysfunction; Diabetes Mellitus, Type 2; Essential Tremor; Joint Diseases; Mental Disorders; Schizophrenia; Substance-Related Disorders; Alcohol Drinking; Amyotrophic Lateral Sclerosis; Anemia, Sickle Cell; Arthritis, Psoriatic; Arthritis, Rheumatoid; Child Development Disorders, Pervasive; Chronic Pain; Dementia; HIV Infections; Irritable Bowel Syndrome; Marijuana Abuse; Migraine with Aura; Migraine without Aura; Multiple Sclerosis; Neuralgia; Opioid-Related Disorders; Pain; Sleep Apnea, Obstructive; Stress Disorders, Post-Traumatic; Torticollis; Tourette Syndrome; Trichotillomania; Anorexia Nervosa; Osteoarthritis, Knee; Anorexia; Nausea; Neoplasms; Vomiting
Cannabinoid CB1 receptor agonist
Small molecule
Approved
MUSCULOSKELETAL; OTHER; RHEUMATOLOGY
ORAL
Kidney Calculi; Renal Colic; Multiple Sclerosis; Paget Disease, Extramammary; Periodontitis; Bursitis; Inflammation; Low Back Pain; Migraine Disorders; Osteoarthritis, Knee; Postoperative Nausea and Vomiting; Sprains and Strains; Tendinopathy; Wounds and Injuries; Acute Pain; Arthralgia; Arthritis, Rheumatoid; Dysmenorrhea; Myalgia; Osteoarthritis; Rheumatic Diseases
Cyclooxygenase inhibitor
Small molecule
Approved
OTHER
ORAL
Anemia; Anemia, Sickle Cell; Arthritis, Rheumatoid; Diabetes Mellitus, Type 2; Fractures, Bone; HIV Infections; Mitochondrial Diseases; Low Back Pain; Periodontitis; Pain; Pharyngitis; Arthralgia; Eye Diseases; Miosis; Myalgia; Rheumatic Diseases
Cyclooxygenase inhibitor
Small molecule
Approved
OTHER
ORAL
Aging; Alcoholism; Depressive Disorder; Fractures, Bone; Neoplasms; Pancreatitis; Periodontitis; Bile Duct Diseases; Carcinoma; Carcinoma, Basal Cell; Mastodynia; Pulmonary Embolism; Wounds and Injuries; Infertility; Osteoarthritis, Hip; Osteoarthritis, Knee; Renal Colic; Spondylitis, Ankylosing; Stomach Ulcer; Toothache; Acute Pain; Arthralgia; Arthritis, Rheumatoid; Cataract; Dysmenorrhea; Eye Diseases; Inflammation; Keratosis, Actinic; Migraine Disorders; Myalgia; Osteoarthritis; Rheumatic Diseases; Sprains and Strains
Cyclooxygenase inhibitor
Small molecule
Approved
CARDIOVASCULAR; OTHER
ORAL
Cerebrovascular Disorders; Intracranial Aneurysm; Schizophrenia; Cocaine-Related Disorders; Infertility; Muscle Cramp; Neuroma, Acoustic; Stroke; Poisoning; Subarachnoid Hemorrhage; Cardiovascular Diseases
Mineralocorticoid receptor antagonist
Small molecule
Approved
OTHER
ORAL
Abortion, Incomplete; Infections; Clostridium Infections; Muscle Cramp; Non-alcoholic Fatty Liver Disease; Premature Birth; Abortion, Spontaneous; Leiomyoma; Menorrhagia; Myoma; Obesity; Pain; Postpartum Hemorrhage; Pre-Eclampsia; Pregnancy; Spondylitis, Ankylosing; Uterine Diseases; Duodenal Ulcer; Gastroesophageal Reflux; Hemorrhage; Osteoarthritis; Peptic Ulcer; Stomach Ulcer
Prostanoid EP3 receptor agonist
Small molecule
Approved
OTHER
ORAL
Anxiety; Bipolar Disorder; Dementia; Depressive Disorder; Developmental Disabilities; Intellectual Disability; Psychotic Disorders; Schizophrenia
Dopamine D2 receptor antagonist
Small molecule
Approved
OTHER
ORAL
Sleep Wake Disorders; Sleep Initiation and Maintenance Disorders
GABA-A receptor; anion channel positive allosteric modulator
Small molecule
Approved
OTHER
ORAL
Arthritis, Rheumatoid; Osteoarthritis; Rheumatic Diseases
Cyclooxygenase-2 inhibitor
Small molecule
Approved
OTHER
INJECTION
Anxiety; Dental Anxiety; Disorders of Excessive Somnolence; Fragile X Syndrome; Idiopathic Hypersomnia; Narcolepsy; Parkinson Disease; Sleep Initiation and Maintenance Disorders; Alcoholism; Obsessive-Compulsive Disorder; Substance-Related Disorders
GABA-A receptor; anion channel allosteric antagonist
Small molecule
Approved
DIABETES DRUGS & ENDOCRINOLOGY; MUSCULOSKELETAL; OTHER; RHEUMATOLOGY
ORAL
Lecithin Cholesterol Acyltransferase Deficiency; Carcinoma, Hepatocellular; Pancreatic Neoplasms; Colorectal Neoplasms; Muscular Diseases; Pain; Sprains and Strains; Acute Pain; Arthritis, Juvenile; Arthritis, Rheumatoid; Osteoarthritis; Rheumatic Diseases
Cyclooxygenase-2 inhibitor
Small molecule
Approved
EMERGENCY MEDICINE; GASTROINTESTINAL; OTHER
INJECTION; ORAL
Brain Diseases; Brain Injuries; Dyspnea; Lecithin Cholesterol Acyltransferase Deficiency; Neuralgia; Opioid-Related Disorders; Pruritus; Small Cell Lung Carcinoma; Amphetamine-Related Disorders; Breast Neoplasms; Cholecystitis; Cocaine-Related Disorders; Dementia; Gastroparesis; Glioma; Hallucinations; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Obsessive-Compulsive Disorder; Pancreatic Neoplasms; Sarcoma; Tobacco Use Disorder; Tonsillitis; Alcoholism; Gastroenteritis; Genital Neoplasms, Female; HIV Infections; Hypotension; Irritable Bowel Syndrome; Pain; Schizophrenia; Syncope; Uterine Cervical Neoplasms; Vomiting; Nausea; Neoplasms; Postoperative Nausea and Vomiting
Serotonin 3a (5-HT3a) receptor antagonist
Small molecule
Approved
OTHER
ORAL
Arthritis, Juvenile; Arthritis, Rheumatoid; Osteoarthritis; Rheumatic Diseases
Cyclooxygenase inhibitor
Small molecule
Approved
IMMUNE SYSTEM; NEUROLOGY DRUGS & NERVOUS SYSTEM; OTHER; PEDIATRICS
ORAL
Alopecia; Child Development Disorders, Pervasive; Glioblastoma; Premature Birth; Psychotic Disorders; Abortion, Spontaneous; Anemia, Sickle Cell; Breast Neoplasms; HIV Infections; Hyperemesis Gravidarum; Intervertebral Disc Displacement; Low Back Pain; Marijuana Abuse; Mucositis; Multiple Sclerosis; Neoplasms; Paget Disease, Extramammary; Peripheral Nervous System Diseases; Postoperative Complications; Prostatic Neoplasms, Castration-Resistant; Rotator Cuff Injuries; Sleep Wake Disorders; Substance-Related Disorders; Substance Withdrawal Syndrome; Tinnitus; Tobacco Use Disorder; Urinary Bladder Neoplasms; Wounds and Injuries; Alcohol Drinking; Alcoholism; Anxiety; Azoospermia; Brain Injuries; Carpal Tunnel Syndrome; Chronic Pain; Cystitis, Interstitial; Delirium; Dementia; Depressive Disorder; Diabetic Neuropathies; Dyspepsia; Epilepsies, Partial; Fibromyalgia; Head and Neck Neoplasms; Herpes Zoster; Hot Flashes; Intervertebral Disc Degeneration; Liver Cirrhosis; Lung Diseases; Neuralgia; Opioid-Related Disorders; Oropharyngeal Neoplasms; Pain; Pelvic Organ Prolapse; Postoperative Nausea and Vomiting; Pruritus; Schizophrenia; Scoliosis; Sleep Initiation and Maintenance Disorders; Tremor; Vomiting; Epilepsy; Neuralgia, Postherpetic; Restless Legs Syndrome; Seizures
Voltage-gated calcium channel modulator
Small molecule
Approved
OTHER
ORAL
Bipolar Disorder; Anemia; Epilepsy; Seizures
Glutamate [NMDA] receptor antagonist
Small molecule
Approved
OTHER
INTRAMUSCULAR; ORAL; SUBCUTANEOUS
Dyskinesia, Drug-Induced; Huntington Disease; Lecithin Cholesterol Acyltransferase Deficiency; Opioid-Related Disorders; Schizotypal Personality Disorder; Amphetamine-Related Disorders; Child Development Disorders, Pervasive; Cocaine-Related Disorders; Obsessive-Compulsive Disorder; Stress Disorders, Post-Traumatic; Substance-Related Disorders; Tourette Syndrome; Alzheimer Disease; Anxiety; Asperger Syndrome; Attention Deficit and Disruptive Behavior Disorders; Conduct Disorder; Dementia; Dementia, Vascular; Depressive Disorder; Depressive Disorder, Major; Developmental Disabilities; Intellectual Disability; Mental Disorders; Neurodevelopmental Disorders; Rett Syndrome; Aggression; Autistic Disorder; Bipolar Disorder; Psychotic Disorders; Schizophrenia
Dopamine D2 receptor antagonist
Small molecule
Approved
NEUROLOGY DRUGS & NERVOUS SYSTEM; OTHER
ORAL
Fasting; HIV Infections; Lecithin Cholesterol Acyltransferase Deficiency; Mental Disorders; Alcoholism; Cocaine-Related Disorders; Cognitive Dysfunction; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Neuralgia, Postherpetic; Neurofibromatosis 1; Opioid-Related Disorders; Substance-Related Disorders; Anxiety; Dementia; Epilepsy, Absence; Feeding and Eating Disorders; Mood Disorders; Obesity; Pain; Peripheral Nervous System Diseases; Schizophrenia; Bipolar Disorder; Depressive Disorder; Epilepsies, Partial; Epilepsy; Epilepsy, Tonic-Clonic; Lennox Gastaut Syndrome; Seizures
Sodium channel alpha subunit blocker
Small molecule
Approved
NEUROLOGY DRUGS & NERVOUS SYSTEM; OTHER
ORAL
Breast Neoplasms; Neoplasms; Schizophrenia; Stress Disorders, Post-Traumatic; Alzheimer Disease; Atrial Fibrillation; Bipolar Disorder; Cerebellar Ataxia; Child Development Disorders, Pervasive; Depressive Disorder; Depressive Disorder, Major; Melanoma; Multiple Sclerosis; Multiple Sclerosis, Chronic Progressive; Muscular Atrophy, Spinal; Obsessive-Compulsive Disorder; Peripheral Nervous System Diseases; Spinal Cord Injuries; Huntington Disease; Multiple System Atrophy; Spinal Cord Diseases; Spinocerebellar Ataxias; Supranuclear Palsy, Progressive; Amyotrophic Lateral Sclerosis
Sodium channel alpha subunit blocker
Small molecule
Approved
DIABETES DRUGS & ENDOCRINOLOGY; OTHER
ORAL
Postoperative Nausea and Vomiting; Sleep Apnea, Obstructive; Stomach Diseases; Alcoholism; Amphetamine-Related Disorders; Anorexia; Anorexia Nervosa; Cachexia; Cocaine-Related Disorders; Fibromyalgia; Paraganglioma; Substance-Related Disorders; Weight Loss; Anxiety; Child Development Disorders, Pervasive; Dementia; Heroin Dependence; Nausea; Schizophrenia; Depressive Disorder; Depressive Disorder, Major; Sleep Initiation and Maintenance Disorders
Adrenergic receptor alpha-2 antagonist
Small molecule
Approved
OTHER
INTRAMUSCULAR; ORAL
Dyskinesia, Drug-Induced; Lecithin Cholesterol Acyltransferase Deficiency; Mood Disorders; Weight Loss; Amyotrophic Lateral Sclerosis; Anorexia Nervosa; Autistic Disorder; Delirium; Opioid-Related Disorders; Vomiting; Alcoholism; Anorexia; Anxiety; Borderline Personality Disorder; Dementia; Depressive Disorder; Depressive Disorder, Treatment-Resistant; Developmental Disabilities; Feeding and Eating Disorders; Gambling; Genital Neoplasms, Female; Huntington Disease; Intellectual Disability; Nausea; Neoplasms; Postoperative Nausea and Vomiting; Testicular Neoplasms; Weight Gain; Bipolar Disorder; Depressive Disorder, Major; Mental Disorders; Psychomotor Agitation; Psychotic Disorders; Schizophrenia
D2-like dopamine receptor antagonist
Small molecule
Approved
NEUROLOGY DRUGS & NERVOUS SYSTEM; OTHER; PEDIATRICS
ORAL
Bulimia Nervosa; Cognitive Dysfunction; Feeding and Eating Disorders; Hernias, Diaphragmatic, Congenital; HIV Infections; Liver Diseases; Alcohol Drinking; Amphetamine-Related Disorders; Brain Ischemia; Deafness; Diabetes Mellitus; Hearing Loss, Sudden; Marijuana Abuse; Multiple Sclerosis; Parkinson Disease; Sciatica; Stress Disorders, Post-Traumatic; Alcoholism; Anxiety; Bipolar Disorder; Bulimia; Cocaine-Related Disorders; Dementia; Depressive Disorder; Diabetes Mellitus, Type 2; Epilepsies, Partial; Epilepsy, Tonic-Clonic; Essential Tremor; Gambling; Headache; Hyperlipidemias; Hypertension; Hypertriglyceridemia; Metabolic Syndrome; Mood Disorders; Obesity; Obsessive-Compulsive Disorder; Pain; Prader-Willi Syndrome; Schizophrenia; Smoking Cessation; Tobacco Use Disorder; Tourette Syndrome; Epilepsy; Lennox Gastaut Syndrome; Migraine Disorders; Seizures
Carbonic anhydrase II inhibitor
Small molecule
Approved
NEUROLOGY DRUGS & NERVOUS SYSTEM; OTHER
SUBCUTANEOUS
Amyotrophic Lateral Sclerosis; Crohn Disease; Macular Degeneration; Multiple Sclerosis, Chronic Progressive; Rett Syndrome; Glaucoma, Angle-Closure; Multiple Sclerosis, Relapsing-Remitting; Optic Neuritis; Multiple Sclerosis; Neoplasms
Unknown
Small molecule
Approved
NEUROLOGY DRUGS & NERVOUS SYSTEM; OTHER
NASAL; ORAL
Migraine Disorders
Serotonin 1b (5-HT1b) receptor agonist
Small molecule
Approved
OTHER
ORAL
Cognitive Dysfunction; Hypotension, Orthostatic; Low Back Pain; Melanoma; Psychotic Disorders; Sleep Apnea Syndromes; Sleep Initiation and Maintenance Disorders; Tinnitus; Tobacco Use Disorder; Alcoholism; Amphetamine-Related Disorders; Cognition; Deglutition Disorders; Depressive Disorder; Opioid-Related Disorders; Ovarian Neoplasms; Parkinson Disease; Schizophrenia; Stress Disorders, Post-Traumatic; Substance-Related Disorders; Alzheimer Disease; Brain Neoplasms; Cocaine-Related Disorders; Depressive Disorder, Major; Fatigue; Multiple Sclerosis; Postpoliomyelitis Syndrome; Sarcoma, Ewing; Sleep Wake Disorders; Stroke; Attention Deficit Disorder with Hyperactivity; Narcolepsy; Sleep Apnea, Obstructive
Dopamine transporter inhibitor
Small molecule
Approved
OTHER
ORAL
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Breast Carcinoma In Situ; Carcinoma, Hepatocellular; Depressive Disorder, Major; Fractures, Bone; Hepatolenticular Degeneration; Hypotension, Orthostatic; Inflammation; Keratosis, Actinic; Mouth Neoplasms; Myositis; Neuroblastoma; Obesity; Triple Negative Breast Neoplasms; Tuberculosis; Uterine Cervical Neoplasms; Amyotrophic Lateral Sclerosis; Back Pain; Brain Neoplasms; Carcinoma, Renal Cell; Central Nervous System Neoplasms; Cerebral Hemorrhage; Endometrial Neoplasms; Esophageal Neoplasms; Facial Pain; Glioblastoma; Graves Ophthalmopathy; Hepatitis B, Chronic; Lymphangioleiomyomatosis; Medulloblastoma; Melanoma; Multiple Myeloma; Multiple Sclerosis; Muscular Atrophy, Spinal; Neuralgia; Neurofibromatosis 1; Obsessive-Compulsive Disorder; Ovarian Neoplasms; Papilloma; Paraganglioma; Paraproteinemias; Peritoneal Neoplasms; Post-Acute COVID-19 Syndrome; Pre-Eclampsia; Prostatic Hyperplasia; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Rotator Cuff Injuries; Sarcoma; Schizophrenia; Severe Acute Respiratory Syndrome; Squamous Cell Carcinoma of Head and Neck; Squamous Intraepithelial Lesions; Stomatitis; Temporomandibular Joint Disorders; Tonsillitis; Toothache; Urinary Bladder Neoplasms; Uterine Cervical Dysplasia; Uterine Neoplasms; Adenoma; Alzheimer Disease; Bipolar Disorder; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Chronic Pain; Colonic Neoplasms; Colorectal Neoplasms; Depression, Postpartum; Depressive Disorder; Gout; Hand-Foot Syndrome; Head and Neck Neoplasms; Hypertension; Influenza, Human; Liver Neoplasms; Low Back Pain; Lung Neoplasms; Macular Degeneration; Memory Disorders; Nasopharyngeal Carcinoma; Osteoarthritis, Hip; Osteoarthritis, Knee; Pancreatic Neoplasms; Pharyngitis; Rectal Neoplasms; Thyroiditis, Subacute; Tobacco Use Disorder; Wounds and Injuries; Acute Pain; Adenomatous Polyposis Coli; Arthritis, Juvenile; Arthritis, Rheumatoid; Dysmenorrhea; Hemorrhage; Migraine Disorders; Neoplasms; Osteoarthritis; Pain; Peptic Ulcer; Rheumatic Diseases; Spondylitis; Spondylitis, Ankylosing; Stroke
Cyclooxygenase-2 inhibitor
Small molecule
Approved
NEUROLOGY DRUGS & NERVOUS SYSTEM; OTHER
ORAL
Amyloid Neuropathies, Familial; Cocaine-Related Disorders; Executive Function; Neuroblastoma; Alcoholism; Brain Injuries; Gambling; Obsessive-Compulsive Disorder; Pick Disease of the Brain; Schizophrenia; Tobacco Use Disorder; Liver Failure; Parkinson Disease
Catechol O-methyltransferase inhibitor
Small molecule
Approved
NEUROLOGY DRUGS & NERVOUS SYSTEM; OTHER
INTRAVENOUS; ORAL
Aphasia; Canavan Disease; Essential Tremor; Lymphoma, Follicular; Stroke; Alzheimer Disease; Anemia, Sickle Cell; Bipolar Disorder; Brain Neoplasms; Cocaine-Related Disorders; Cognitive Dysfunction; Dyskinesia, Drug-Induced; Epilepsy, Absence; Epilepsy, Reflex; Glioblastoma; Leukemia, Myeloid, Acute; Neuralgia, Postherpetic; Neuroblastoma; Obsessive-Compulsive Disorder; Opioid-Related Disorders; Paraganglioma; Parkinson Disease; Polyneuropathies; Psychotic Disorders; Restless Legs Syndrome; Stress Disorders, Post-Traumatic; Torticollis; Alcoholism; Anxiety; Dementia; Depressive Disorder; Epilepsies, Partial; Movement Disorders; Panic Disorder; Schizophrenia; Status Epilepticus; Subarachnoid Hemorrhage; Substance Withdrawal Syndrome; Epilepsy; Epilepsy, Tonic-Clonic; Seizures
Synaptic vesicle glycoprotein 2A modulator
Small molecule
Approved
NEUROLOGY DRUGS & NERVOUS SYSTEM; OTHER
ORAL
Amphetamine-Related Disorders; Epilepsy; Gastrointestinal Stromal Tumors; Obesity; Cocaine-Related Disorders; Parkinson Disease
Catechol O-methyltransferase inhibitor
Small molecule
Approved
NEUROLOGY DRUGS & NERVOUS SYSTEM; OTHER
ORAL
Sleep Wake Disorders; Anxiety; Dementia; Depressive Disorder; Schizophrenia; Sleep Initiation and Maintenance Disorders
GABA A receptor alpha-1/beta-1/gamma-2 positive allosteric modulator
Small molecule
Approved
NEUROLOGY DRUGS & NERVOUS SYSTEM; OTHER
TRANSDERMAL
Amphetamine-Related Disorders; Central Nervous System Diseases; Cocaine-Related Disorders; Down Syndrome; Substance-Related Disorders; Anxiety; Brain Injuries; Cognitive Dysfunction; Delirium; Dementia, Vascular; Depressive Disorder; Neurobehavioral Manifestations; Schizophrenia; Supranuclear Palsy, Progressive; Alzheimer Disease; Dementia; Parkinson Disease
Cholinesterases; ACHE & BCHE inhibitor
Small molecule
Approved
MUSCULOSKELETAL; OTHER
ORAL
Lupus Erythematosus, Systemic; Dysmenorrhea; Osteoarthritis, Knee; Pharyngitis; Pregnancy; Toothache; Low Back Pain; Migraine Disorders; Pain; Prostatic Neoplasms; Shoulder Pain; Spondylitis, Ankylosing; Tuberculosis; Arthritis, Juvenile; Arthritis, Rheumatoid; Osteoarthritis; Rheumatic Diseases
Cyclooxygenase-2 inhibitor
Small molecule
Approved
NEUROLOGY DRUGS & NERVOUS SYSTEM; OTHER
ORAL
Cocaine-Related Disorders; Hearing Loss, Noise-Induced; Tobacco Use Disorder; Essential Tremor; Hearing Loss; Obesity; Parkinson Disease; Alcoholism; Epilepsy, Complex Partial; Feeding and Eating Disorders; Migraine Disorders; Psychotic Disorders; Schizophrenia; Smoking Cessation; Weight Gain; Epilepsies, Partial; Epilepsy; Seizures
Sodium channel alpha subunit blocker